Special items: Ovarian Cancer and Us blog best viewed in Firefox

▼
Showing posts with label pharma. Show all posts
Showing posts with label pharma. Show all posts
Wednesday, March 28, 2012

Clinical Oncology News - Zoledronic Acid Debate in Breast Cancer Continues

›
Clinical Oncology News - Zoledronic Acid Debate in Breast Cancer Continues San Antonio—Long-term results of the ABCSG-12 trial and subana...
Tuesday, March 13, 2012

open access: PLoS Medicine: A Comparison of DSM-IV and DSM-5 Panel Members' Financial Associations with Industry: A Pernicious Problem Persists

›
PLoS Medicine: A Comparison of DSM-IV and DSM-5 Panel Members' Financial Associations with Industry: A Pernicious Problem Persists  In...
Tuesday, January 24, 2012

open access: PLoS Medicine: Challenging Medical Ghostwriting in US Courts - eg. ethics, legal liabilities, patient harm.....

›
Introduction "Complaints about the ethics of medical ghostwriting have increased in the last decade, but little has changed [1] – [1...
Tuesday, June 28, 2011

Author Insights: Some Clinical Trials Intended for Drug Marketing, Not Advancing Science « news@JAMA (seeding trials)

›
Friday, May 13, 2011

Pharma: Pain Therapeutics - SMi Group - Event Details - UK - Overview

›
This conference seeks to address Recent successes and failures for new drugs in development Translational pain R&D Current huma...
Tuesday, January 25, 2011

Cost recovery (handouts) trumps concerns about conflicted interest -- Canadian Medical Association Journal

›
Although there's widespread variation in the policies that Canadian medical schools have toward pharmaceutical and medical devices indus...
Monday, November 15, 2010

Session Overviews Pharma-Nutrition 2011 Conference Netherlands conference notice/program

›